SLC2A4 and Insulin resistance: All three insulin resistance treatments impaired insulin-stimulated GLUT4 translocation in response to 0.5 or 100 nM insulin in wild-type or HA-GLUT4-mRuby3-expressing cells (Fig. 5a, c, Supplementary Fig. 7b–e).